GlassScriptPhysician profile
James Cosentino
NPI 1821225715
$17,842.73
in general payments reported to CMS, 2019-2025
32 companies · $8,599 in 2025
The $8,599 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,713 · 2020: $735 · 2021: $1,096 · 2022: $1,677 · 2023: $2,022 · 2024: $2,000 · 2025: $8,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,000 · Food and Beverage: $5,553 · Travel and Lodging: $68.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,000.00 |
| Food and Beverage | $5,553.36 |
| Travel and Lodging | $68.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,311.42 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,864.48 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,566.68 | 2019-2025 | Ofev, Jascayd |
| Philips North America LLC | $500.68 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Ambu INC. | $465.35 | 2022-2024 | |
| Genzyme Corporation | $454.63 | 2019-2025 | |
| Amgen INC. | $408.60 | 2022-2025 | Tezspire |
| Mylan Specialty L.P. | $356.93 | 2020-2024 | Yupelri |
| United Therapeutics Corporation | $277.16 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Regeneron Healthcare Solutions, INC. | $274.74 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $193.13 | 2021-2023 | Acthar |
| Insmed, INC. | $142.44 | 2019 | |
| Smith+Nephew, INC. | $131.93 | 2019 | |
| Abiomed | $126.64 | 2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $110.20 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $94.22 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $88.94 | 2019-2025 | Uptravi |
| Sanofi-Aventis U.S. LLC | $76.99 | 2022 | |
| Grifols USA, LLC | $63.92 | 2019-2020 | |
| Inspire Medical Systems, INC. | $48.51 | 2023-2024 | Inspire |
| Genentech USA, INC. | $46.29 | 2019-2023 | Xolair |
| Ani Pharmaceuticals, INC. | $34.93 | 2022-2023 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $34.16 | 2025 | Yupelri |
| Vifor Pharma, INC. | $33.91 | 2022-2023 | Veltassa |
| Pfizer INC. | $29.11 | 2022-2023 | |
| Electromed, INC. | $20.36 | 2021 | |
| Baxter Healthcare | $17.00 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $15.91 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $14.03 | 2020 | |
| Circassia INC. | $13.72 | 2019 | |
| Optinose US, INC. | $12.94 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cosentino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.